Status:
UNKNOWN
Transdermal Lidocaine for Pain Control During Diagnostic Office Hysteroscopy
Lead Sponsor:
Aswan University Hospital
Conditions:
Infertility, Female
Eligibility:
FEMALE
18-60 years
Phase:
NA
Brief Summary
To compare the effectiveness of Transdermal Lidocaine for Pain Control During Diagnostic Office Hysteroscopy
Detailed Description
hysteroscopy is commonly used in the diagnosis and treatment of intrauterine lesions such as polyps, fibroids, septa, and adhesions, and in the presence of abnormal bleeding and during the removal of a...
Eligibility Criteria
Inclusion
- patients with an indication for office hysteroscopy
Exclusion
- patient refuse to participant
- contraindication for lidocaine patch
Key Trial Info
Start Date :
September 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2021
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04518202
Start Date
September 1 2020
End Date
September 30 2021
Last Update
August 19 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aswan University Hospital
Aswān, Egypt, 81528